申请人:Ando Shigeru
公开号:US20140329829A1
公开(公告)日:2014-11-06
The disclosure relates to Compounds of Formula (I)
and pharmaceutically acceptable derivatives thereof, where R
1
, R
4
, R
8
, R
9
, and m are as defined herein, compositions comprising an effective amount of a Compound of Formula (I) or a pharmaceutically acceptable derivative thereof, and methods for treating or preventing a condition such as pain, pain associated with osteoarthritis, osteoarthritis, UI, an ulcer, IBD, and IBS, comprising administering to an animal in need thereof an effective amount of a Compound of Formula (I) or a pharmaceutically acceptable derivative thereof.
本公开涉及化合物公式(I)及其药学上可接受的衍生物,其中R1,R4,R8,R9和m的定义如本文所述,包括含有化合物公式(I)或其药学上可接受的衍生物的有效量的组合物,以及用于治疗或预防疼痛、与骨关节炎相关的疼痛、骨关节炎、尿失禁、溃疡、炎症性肠病和肠易激综合征等疾病的方法,包括向需要治疗的动物中施用化合物公式(I)或其药学上可接受的衍生物的有效量。